Summary
An investigation of the urinary metabolites of the oral progestational agent dydrogesterone in healthy women of childbearing age is reported. The drug was administered in 3H-labelled form and the urine of the first 8 h, containing on average 38% of the radioactivity administered, was used as the source of the metabolites. It was fortified with urine collected during the first 8 h of a similar study with non labe lied dydrogesterone. After enzymatic hydrolysis of conjugated metabolites, 43 different chemical species were isolated by means of extraction, followed by column and thin layer chromatography. Three of these metabolites, constituting about 70% of the urinary radioactivity, were positively identified as 20α-hydroxy-9β, 10α-pregna-4, 6-diene-3-one (52%), 21-hydroxy-9β, 10α-pregna-4, 6-diene-3, 20-dione (18%) and 16α-hydroxy-9β, 10α-4, 6-diene-3, 20-dione (1%). Of the remainder, 20 (13%) were tentatively characterized as various products of oxidative attack, all probably having the 4, 6-diene-3-one configuration intact. It is concluded that the 4, 6-diene-3-one configuration is metabolically stable in combination with the 9β, 10α configuration. This finding may explain why dydrogesterone, in contrast to progesterone, is orally effective, and lacks estrogenic properties.
Similar content being viewed by others
Abbreviations
- LC:
-
liquid chromatography
- GPC:
-
gel permeation chromatography
- TLC:
-
thin layer chromatography
- HPLC:
-
high performance liquid chromatography
- LSC:
-
liquid scintillation counting
- TSIM:
-
trimethylsilylimidazole
- TMS:
-
trimethylsilyl
- GLC:
-
gas-liquid chromatography
- FID:
-
flame ionisation detector
- NMR:
-
nuclear magnetic resonance spectrometry
- MS:
-
mass spectrometry
- GC-MS:
-
gas chromatography-mass spectrometry
- mCi:
-
millicurie
- PPO:
-
2,5 -diphenyloxazole
- POPOP:
-
1,4-di-(2-(5-phenyloxazolyl)-benzene
References
Tillinger, K.G. and Diczfalusy, E. (1960): Progestational activity of stereoisomeric progesterone-analogues following oral administration in amenorrhoea. Acta Endocrinol.35, 197–203.
Bishop, P.M.F., Borell, U., Diczfalusy, E. and Tillinger, K.G. (1962): Effect of dydrogesterone on human endometrium and ovarian activity. Acta Endocrinol.40, 203–216.
Diczfalusy, E., Tillinger, K.G., Esser, R.J.E. and Houtman, A.C. (1963): Metabolism of some progestationally active 9β, 10α-steroids in man. Nature200, 79–80.
Dixon, R., Tormey, P., Lambe, R. and Darragh, A. (1973): Retro Steroids I. Metabolism of the progestogen 6-chloro-9β, 10α-pregna-1,4, 6-trien-3,20-dione in man. Steroids22, 35–46.
Davis, M.E. and Plotz, E.J. (1957): The metabolism of progesterone and its clinical use in pregnancy. Recent progress in human research13, 347–379.
Aydar, C.K. and Greenblatt, R.B. (1964): 6-dehydro-retroprogesterone (Duphaston). An interesting progesterone-like compound. Internat. J. Fertility IX, 585–595.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
van Amsterdam, P.H., Overmars, H., Scherpenisse, P.M. et al. Dydrogesterone: Metabolism in man. European Journal of Drug Metabolism and Pharmacokinetics 5, 173–184 (1980). https://doi.org/10.1007/BF03189462
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03189462